Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (366 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 06 May 2026 – 20 Aug 2026, limited by Axis Nifty India Defence Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Axis Nifty India Defence Index Fund | Nifty 500 |
|---|---|---|
| 06 May 2026 | ₹100.00 | ₹100.00 |
| 15 May 2026 | ₹98.44 | ₹97.40 |
| 24 May 2026 | ₹99.50 | ₹97.92 |
| 02 Jun 2026 | ₹98.27 | ₹97.35 |
| 10 Jun 2026 | ₹98.25 | ₹96.11 |
| 19 Jun 2026 | ₹104.75 | ₹100.05 |
| 28 Jun 2026 | ₹102.65 | ₹99.91 |
| 07 Jul 2026 | ₹103.58 | ₹101.02 |
| 16 Jul 2026 | ₹101.41 | ₹100.43 |
| 25 Jul 2026 | ₹102.13 | ₹99.05 |
| 02 Aug 2026 | ₹101.87 | ₹101.41 |
| 11 Aug 2026 | ₹104.69 | ₹102.37 |
| 20 Aug 2026 | ₹107.01 | ₹101.64 |
| Metric | Axis · Regular NAV ₹10.84 Very High risk Unrated | Category median Index Funds · 366 funds |
|---|---|---|
| — | +5.43% | |
| — | +8.41% | |
| — | +8.95% | |
| — | +11.28% | |
| +7.01% | +7.40% | |
| +35.01% | — | |
| — | +11.37% | |
| — | +13.00% | |
| — | +11.07% | |
| Risk | ||
| 20.89% | 13.88% | |
| — | 0.25 | |
| — | 0.35 | |
| -6.62% | -16.66% | |
| Nifty 500 | — | |
| — | +0.30% | |
| — | 1.00 | |
| — | 101.3% | |
| — | 98.8% | |
| 1.64% | 0.96% | |
| ₹176.87Cr | ₹182.17Cr | |
| 0.25% | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| — | 35% | |
| Rohit Gautam · 0.4y | — | |
| 06 May 2026 | — | |
| 19 | — | |
| 88.5% | — | |
| -0.9% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.